|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
US4755465A
(en)
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
|
US5281532A
(en)
|
1983-07-27 |
1994-01-25 |
Mycogen Corporation |
Pseudomas hosts transformed with bacillus endotoxin genes
|
|
US4695462A
(en)
|
1985-06-28 |
1987-09-22 |
Mycogen Corporation |
Cellular encapsulation of biological pesticides
|
|
US4695455A
(en)
|
1985-01-22 |
1987-09-22 |
Mycogen Corporation |
Cellular encapsulation of pesticides produced by expression of heterologous genes
|
|
GB8517071D0
(en)
|
1985-07-05 |
1985-08-14 |
Hoffmann La Roche |
Gram-positive expression control sequence
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
DK203187A
(da)
|
1986-04-22 |
1987-10-23 |
Immunex Corp |
Human g-csf proteinekspression
|
|
NO176799C
(no)
|
1986-12-23 |
1995-05-31 |
Kyowa Hakko Kogyo Kk |
DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
|
|
JP2618618B2
(ja)
|
1988-03-04 |
1997-06-11 |
協和醗酵工業株式会社 |
抗g−csf誘導体、nd28モノクローナル抗体
|
|
US4904584A
(en)
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
|
US5128130A
(en)
|
1988-01-22 |
1992-07-07 |
Mycogen Corporation |
Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
|
|
US5055294A
(en)
|
1988-03-03 |
1991-10-08 |
Mycogen Corporation |
Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
|
|
CA1340810C
(en)
|
1988-03-31 |
1999-11-02 |
Motoo Yamasaki |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
US5169760A
(en)
|
1989-07-27 |
1992-12-08 |
Mycogen Corporation |
Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
|
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
DE4014750A1
(de)
|
1990-05-08 |
1991-11-14 |
Boehringer Mannheim Gmbh |
Muteine des granulozyten-stimulierenden faktors (g-csf)
|
|
IE912365A1
(en)
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
|
JPH05502463A
(ja)
|
1990-09-28 |
1993-04-28 |
オーソ・フアーマシユーチカル・コーポレーシヨン |
ハイブリツド成長因子
|
|
US5508192A
(en)
|
1990-11-09 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Bacterial host strains for producing proteolytically sensitive polypeptides
|
|
DE4105480A1
(de)
|
1991-02-21 |
1992-08-27 |
Boehringer Mannheim Gmbh |
Verbesserte aktivierung von rekombinanten proteinen
|
|
US6171824B1
(en)
|
1991-08-30 |
2001-01-09 |
Fred Hutchinson Cancer Research Center |
Hybrid cytokines
|
|
US6057133A
(en)
|
1992-11-24 |
2000-05-02 |
G. D. Searle |
Multivariant human IL-3 fusion proteins and their recombinant production
|
|
ITFI940106A1
(it)
|
1994-05-27 |
1995-11-27 |
Menarini Ricerche Sud Spa |
Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
IT1285405B1
(it)
|
1995-06-06 |
1998-06-03 |
Alza Corp |
Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
|
|
WO1999058662A1
(fr)
|
1998-05-14 |
1999-11-18 |
Merck Patent Gmbh |
Proteine fusionnee
|
|
US20030167531A1
(en)
*
|
1998-07-10 |
2003-09-04 |
Russell Douglas A. |
Expression and purification of bioactive, authentic polypeptides from plants
|
|
US7001892B1
(en)
*
|
1999-06-11 |
2006-02-21 |
Purdue Research Foundation |
Pharmaceutical materials and methods for their preparation and use
|
|
KR100358948B1
(ko)
|
2000-03-31 |
2002-10-31 |
한국과학기술원 |
인체 과립성 백혈구의 콜로니 자극인자를 분비하는 대장균
|
|
AU9084601A
(en)
|
2000-09-08 |
2002-03-22 |
Massachusetts Inst Technology |
G-csf analog compositions and methods
|
|
KR20030074785A
(ko)
|
2001-02-06 |
2003-09-19 |
메르크 파텐트 게엠베하 |
감소된 면역원성을 갖는 개질 과립구 집락 자극인자(g-csf)
|
|
JP4279554B2
(ja)
|
2001-02-19 |
2009-06-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
T細胞エピトープの識別方法および低減された免疫原性を有する分子の製造方法
|
|
PL362324A1
(pl)
|
2001-02-19 |
2004-10-18 |
Merck Patent Gmbh |
Sztuczne białko o obniżonej immunogeniczności
|
|
KR100961859B1
(ko)
|
2001-07-11 |
2010-06-09 |
맥시겐 홀딩스 엘티디 |
지-씨에스에프 접합체
|
|
US20040247562A1
(en)
|
2001-09-28 |
2004-12-09 |
Sang Yup Lee |
Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
|
|
EP2292273A3
(en)
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodeling and glycoconjugation of peptides
|
|
AU2003210806A1
(en)
|
2002-03-05 |
2003-09-22 |
Eli Lilly And Company |
Heterologous g-csf fusion proteins
|
|
SI21273A
(sl)
|
2002-07-31 |
2004-02-29 |
LEK farmacevtska dru�ba d.d. |
Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
|
|
US7344858B2
(en)
|
2002-08-31 |
2008-03-18 |
Cj Corp |
Glycosylated human granulocyte colony-stimulating factor (G-CSF) isoform
|
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
|
JP5544063B2
(ja)
*
|
2003-08-13 |
2014-07-09 |
サンド・アクチエンゲゼルシヤフト |
組換えポリペプチドの生産のための発現ベクター、形質転換宿主細胞及び発酵方法
|
|
EP1692282B1
(en)
|
2003-11-19 |
2012-08-08 |
Pfenex, Inc. |
Improved protein expression systems in auxotrophic Pseudomonas fluorescens
|
|
BRPI0416807A
(pt)
|
2003-11-21 |
2007-01-09 |
Dow Global Technologies Inc |
sistemas de expressão aperfeiçoados com secreção de sistema sec
|
|
CN101031655A
(zh)
|
2004-07-26 |
2007-09-05 |
陶氏环球技术公司 |
通过株工程改进蛋白表达的方法
|
|
EP1828241A1
(en)
|
2004-12-23 |
2007-09-05 |
Laboratoires Serono S.A. |
G-csf polypeptides and uses thereof
|
|
GB0605684D0
(en)
|
2006-03-21 |
2006-05-03 |
Sicor Biotech Uab |
Method For Purifying Granulocyte-Colony Stimulating Factor
|
|
KR20090018799A
(ko)
|
2006-05-30 |
2009-02-23 |
다우 글로벌 테크놀로지스 인크. |
코돈 최적화 방법
|
|
KR101491867B1
(ko)
*
|
2007-01-31 |
2015-02-10 |
피페넥스 인크. |
증가된 발현을 위한 박테리아 리더 서열
|
|
US9580719B2
(en)
*
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
US9394571B2
(en)
*
|
2007-04-27 |
2016-07-19 |
Pfenex Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
CA2695374A1
(en)
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|